ProfileGDS5678 / 1450623_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.221898
GSM967853U87-EV human glioblastoma xenograft - Control 210.291498
GSM967854U87-EV human glioblastoma xenograft - Control 39.9889698
GSM967855U87-EV human glioblastoma xenograft - Control 410.279398
GSM967856U87-EV human glioblastoma xenograft - Control 510.403698
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.057298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.239898
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.27398
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.143698
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.307498
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.505398
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.278798
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.583398
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.420998